📘 A Swedish university has studied Flexovital N.O.RDIC. The results? Better organ function and protection for the heart, blood vessels, and kidneys.
Flexovital N.O.RDIC is based on the discovery of nitric oxide – a molecule that was awarded the Nobel Prize and is behind several modern heart and blood pressure medications.
When one of Sweden’s leading universities wanted to investigate the effects of the product in an advanced animal model, we hoped to demonstrate a positive impact on blood vessels, the heart, and metabolism.
🧪 Study summary
✅ Objective: Investigate whether Flexovital N.O.RDIC can protect the body from damage caused by a Western diet, obesity, and type 2 diabetes
✅ Model: Specially designed animal model
✅ Time period: 3 months
✅ Product: Flexovital N.O.RDIC (daily dosage)
📊 Results: Exceeded expectations
The study showed several clear effects in the group that received Flexovital N.O.RDIC – compared to the control group:
🫀 Protective effects on the heart and blood vessels
⚖️ Reduced weight gain (22%)
💧 75% improved kidney function
(increased filtration – the body’s detoxification ability was strengthened)
🧬 Lower blood sugar and reduced inflammation
(both are central factors behind many lifestyle diseases)
Results
Reduced weight gain (22%):
One of the most impressive findings was a 22% reduction in weight gain in the group receiving Flexovital+N.O.RDIC compared to the control group. This suggests that Flexovital+N.O.RDIC may effectively support weight control.
Improved kidney function by 75%:
The group receiving Flexovital exhibited significantly improved kidney function (kidney filtration improved by 75%) compared to those not receiving the product.
Protective effects on the heart and blood vessels:
Flexovital+N.O.RDIC showed strong protective effects on the heart and blood vessels. In the group that did not receive Flexovital, Troponin levels increased by 250%, whereas in the Flexovital group, the increase was 0%.
Additional effects:
Blood sugar levels improved, and inflammation was reduced